MOST NOTEWORTHY:

• Deutsche Bank downgraded shares of Momenta Pharmaceuticals Inc (NASDAQ: MNTA) to Hold from Buy and lowered their target to $6 following the FDA's non-approvable letter for M-Enox.
• Banc of America downgraded shares of The Interpublic Group of Companies Inc (NYSE: IPG) to Neutral from Buy to reflect the economic uncertainty and concerns regarding the company's relative revenue growth.
• Lionbridge Technologies Inc (NASDAQ: LIOX) was downgraded to Sell from Neutral at Goldman Sachs following disappointing Q3 results and guidance.
• Credit Suisse downgraded PetroChina Company Limited (NYSE: PTR) to Underperform from Neutral based on lack of catalysts.
• Jefferies lowered its rating on Collagenex Pharmaceuticals Inc (NASDAQ: CGPI) to Hold from Buy to reflect a lack of near-term catalysts given the company's thin pipeline.

• JP Morgan removed Cognizant Technology Solutions Corporation (NASDAQ: CTSH) from its Focus List and downgraded Performance Food Group Company (NASDAQ: PFGC) to Underweight from Overweight.
• Friedman Billings downgraded Charlotte Russe Holding Inc (NASDAQ: CHIC) to Market Perform from Outperform.
• Jefferies downgraded Forest Oil Corporation (NYSE: FST) to Hold from Buy.

Analyst downgrades: MNTA, IPG, LIOX, PTR and CGPI originally appeared on BloggingStocks on Wed, 07 Nov 2007 10:30:00 EST. Please see our terms for use of feeds.